Disturbed atrial metabolism, shear stress, and cardiac load contribute to atrial fibrillation after ablation: AXAFA biomolecule study
Winnie Chua(University of Birmingham), Paulus Kirchhof(Universität Hamburg), Gerhard Hindricks(Humboldt-Universität zu Berlin), Jonathan P. Piccini(Clinical Research Institute), Tanja Zeller(Universität Hamburg), Ulrich Schotten(Maastricht University), Larissa Fabritz(University of Birmingham), Alya Khashaba(University of Birmingham), Lluı́s Mont(Hospital Clínic de Barcelona), Ursula‐Henrike Wienhues‐Thelen(Roche (Switzerland)), Renate B. Schnabel(Universität Hamburg), Hansel Canagarajah(University of Birmingham), Karl Georg Hæusler(Universitätsklinikum Würzburg), Jens Cosedis Nielsen(Aarhus University Hospital), Luigi Di Biase(Albert Einstein College of Medicine)
Cited by 24
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|EP Europace|2016|6.5k
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
|European Heart Journal|2016|6.4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k